T3513 |
GSK180736A
|
817194-38-0
|
98%
|
|
GSK180736A is an effective and selective GRK2 inhibitor (IC50: 0.77 μM) and >100-fold selectivity over other GRKs. It is a weak inhibitor of PKA (IC50: 30 μM), b...
|
T6057 |
URMC-099
|
1229582-33-5
|
98%
|
|
URMC-099 is an orally bioavailable, brain penetrant MLK inhibitor (IC50: 19/42/14/150 nM, for MLK1/MLK2/MLK3/DLK), and also inhibits LRRK2 activity (IC50: 11 nM)...
|
T10358 |
Netarsudil Dihydrochloride
|
1253952-02-1
|
98%
|
|
Netarsudil hydrochloride is an inhibitor of Rho-associated protein kinase (ROCK) and norepinephrine transporter (NET) with effective in intraocular pressure (IOP...
|
T12747 |
ROCK2-IN-2
|
1995065-79-6
|
98%
|
|
ROCK2-IN-2 is a selective inhibitor of ROCK2 (IC50 of <1 μM).
|
T26078 |
Rhodblock 6
|
886625-06-5
|
98%
|
|
Rhodblock 6 is a Rho kinase (ROCK) inhibitor that inhibits the localization of phosphorylated MRLC (Myosin Regulatory Light Chain) and acts by specifically inhib...
|
T77609 |
WAY-656935
|
852902-81-9
|
98%
|
|
WAY-656935 inhibits ROCK.
|
T36196 |
CAY10746
|
2247240-76-0
|
98%
|
|
CAY10746 is a selective Rho kinase (ROCK) inhibitor that inhibits ROCK I and ROCK II with IC50 values of 0.014 μM and 0.003 μM, respectively.CAY10746 can be used...
|
T6321 |
Tofacitinib
|
477600-75-2
|
98%
|
|
Tofacitinib is an oral, small molecule inhibitor of Janus kinases that is used to treat moderate-to-severe rheumatoid arthritis.
|
T4488 |
GSK-25
|
874119-56-9
|
98%
|
|
GSK-25 maintains good selectivity against a panel of 31 kinases, as well as RSK1 and p70S6K (RSK1 IC50 of 398 nM, p70S6K IC50 of 1000nM), and a dramatically impr...
|
T3060 |
Fasudil hydrochloride
|
105628-07-7
|
98%
|
|
Fasudil Hydrochloride is a potent inhibitor of ROCK1, PKA, PKC, and MLCK with Ki of 0.33 μM, 1.0 μM, 9.3 μM and 55 μM, respectively.
|
T1606 |
Fasudil
|
103745-39-7
|
98%
|
|
Fasudil is a potent inhibitor of ROCK1, PKA, PKC, and MLCK.
|
TQ0319 |
Ripasudil
|
887375-67-9
|
98%
|
|
Ripasudil (K-115) hydrochloride dihydrate is a specific ROCK inhibitor (IC50s: 51/19 nM for ROCK1/ROCK2).
|
T7885 |
Afuresertib hydrochloride
|
1047645-82-8
|
98%
|
|
Afuresertib hydrochloride is an inhibitor of Akt kinase (Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively)
|
T19913 |
CKI-7
|
1177141-67-1
|
98%
|
|
CKI-7 2HCl is an inhibitor of casein kinase 1 (CK1).
|
T9652 |
SB-747651A Dihydrochloride
|
1781882-72-1
|
98%
|
|
SB-747651A dihydrochloride is an ATP-competitive mitogen- and stress-activated kinase 1 (MSK1) inhibitor with an IC 50 of 11 nM. SB-747651A dihydrochloride also ...
|
T6867 |
Belumosudil
|
911417-87-3
|
98%
|
|
KD025 is an orally available, and specific ROCK2 inhibitor (IC50/Ki: 60/41 nM).
|
TQ0110 |
ROCK-IN-2
|
867017-68-3
|
98%
|
|
Azaindole 1 is a selective and ATP-competitive ROCK inhibitor with IC50 of 0.6 and 1.1 nM for human ROCK-1 and ROCK-2.
|
T2633 |
GSK429286A
|
864082-47-3
|
98%
|
|
GSK429286A is a specific inhibitor of ROCK1/2 (IC50: 14/63 nM).
|
T7301 |
BDP5290
|
1817698-21-7
|
98%
|
|
BDP5290 is a potent inhibitor of both ROCK and MRCK(IC50s of 5 nM, 50 nM, 10 nM and 100 nM for ROCK1, ROCK2, MRCKα and MRCKβ, respectively.)
|
T23308 |
SAR407899 hydrochloride
|
923262-96-8
|
98%
|
|
ATP-competitive ROCK inhibitor
|